News + Font Resize -

Troikaa Pharma bags Excellence Award for its painless diclofenac injection
Our Bureau, Bangalore | Friday, May 14, 2010, 08:00 Hrs  [IST]

Ahmedabad-based Troikaa Pharmaceuticals Ltd has won the award for its painless diclofenac injection, ‘Dynapar AQ’.

The award for excellence in ‘Research in Science and Technology’ 2009 was instituted by the Federation of Gujarat Industries (FGI). Troikaa won the award for its in-house research in developing the world's first painless diclofenac injection.

Ketan Patel, managing director, Troikaa Pharmaceuticals said, “The award recognizes our commitment to develop innovative drug delivery systems for patients. This is the second award conferred on the company for the innovative product Dynapar AQ. Given our inherent focus on customer-centric innovations, hopefully there will be more recognition in the years to come.”

Within two and a half years of launch, Dynapar AQ is the second largest brand of diclofenac injections in the country. The company has been granted the patent for this product in India as well as in 29 other countries and is in the process of procuring patents in 70 other countries.

Diclofenac injections are routinely used for management of acute pain and inflammation. The company claimed that Dynapar AQ is the world’s only diclofenac injections that can be administered in the arm muscles, especially useful in obese and overweight patients. It is also the first diclofenac available in pre-filled syringes,he added.

FGI presents biennial awards for excellence in economic, societal and scientific areas. This year, FGI has constituted awards for excellence in 13 categories across different fields.

Dr Montek Singh Ahluwalia, deputy chairman, Planning Commission, presented the award at a function organized by FGI.

The 26 year-old Troikaa Pharmaceuticals holds patented technology platforms for various Novel Drug Delivery Systems including Intra-oral, Oral, Parenteral, Sustained Release and Topical. It has manufacturing facilities located in Ahmedabad and Dehradun (Uttaranchal). The Ahmedabad facility at Thol, an industrial area 25 km from the city, is manufactures high quality critical care Injectables, Tablets and Topical preparations.

Post Your Comment

 

Enquiry Form